by Garth Sundem | May 21, 2019 | Featured, Latest News, Patient Care
D. Ross Camidge, MD, PhD Brigatinib is a next-generation ALK inhibitor that earned FDA approval in 2017 as a second-line therapy after treatment with crizotinib for ALK-positive non-small cell lung cancer. Recently, clinical trial results published in the New England...
by Taylor Abarca | Apr 29, 2019 | Featured, Latest News, Patient Care
When you or someone you love is diagnosed with cancer, the days or weeks following can be overwhelming. Often, patients have to travel to different doctors at different locations for scans and other tests before a care team can recommend the best treatment plan. At...
by CU Cancer Center | Apr 24, 2019 | Latest News, Patient Care
What is esophageal cancer? Esophageal cancer is cancer that arises in the esophagus – a hollow, muscular tube that is about a foot long. It helps pass food and liquids from the back of the mouth to the stomach. The esophagus lies just behind the trachea and in front...
by CU Cancer Center | Mar 28, 2019 | Latest News, Patient Care
In recognition of its impact, the Colorado Cancer Screening Program (CCSP) received a special proclamation from the Colorado General Assembly at the State Capitol in Denver. CCSP focuses on cancer prevention and helps reduce barriers to care. State Rep. Perry Will...
by Taylor Abarca | Mar 22, 2019 | Featured, Patient Care
Diagnosed with stage 3 colorectal cancer at just 38 years old, Jimmy Zannon was a far cry from the “typical” patient. Colorectal cancer was once (and often is still) considered a disease of the elderly. With the average age of diagnosis being 68 in men and 72 in...
by Taylor Abarca | Mar 14, 2019 | Featured, Latest News, Patient Care, Research
Colorectal cancer is unique in that, unlike many other cancers, we know how it progresses from healthy to cancerous. We also know how to prevent it and catch it in its early stages, making it one of the only truly preventable cancers. Unfortunately, even with this...
